OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
April 13, 2023
The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.
April 12, 2023
Michalle Adkins, director of Life Sciences Consulting at Emerson, discusses the structure of manufacturing organizations and how novel technologies may play a role in operations.
Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.
The new site will include state-of-the-art cleanroom facilities, laboratories, R&D, and office spaces.
The decision was issued in a joint statement by the FDA Commissioner and Chief Scientist, and effective on April 11.
The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of CHO cell lines.
April 11, 2023
A document signed by members of more than 400 companies and investment firms decries the decision made by a federal judge concerning mifepristone, a medication used in abortions.
April 10, 2023
Will court challenges to FDA’s oversight authority open the door for multiple lawsuits to block agency decisions on all sides?
April 07, 2023
The agency is dealing with high demand for staff because of a surge in the development of cell and gene therapies.
If approved, Johnson & Johnson would pay $8.9 billion to resolve all current and future claims in its ongoing talc litigation.